Irvine Scientific Announces Expansion Of BalanCD™ Product Line To Serve Vaccine Market

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific is pleased to announce the launch of its BalanCD™ MDCK cell culture medium, a next generation cell culture product responding to today’s requirements for media used in cell-based vaccine manufacturing. This new flagship product expands Irvine Scientific’s current BalanCD product portfolio of animal component-free and chemically-defined media with the addition of a new purpose-built product.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC